Apoquel 3.6 mg

APOQUEL 3.6 MG chewable tablets contain oclacitinib, a medication used to manage itch and inflammation in dogs. This prescription treatment is designed for oral administration and is manufactured by Zoetis Canada Inc.

APOQUEL 3.6 MG is primarily used to control itching and inflammation associated with allergic dermatitis and other skin conditions in dogs. Veterinarians may prescribe oclacitinib for dogs experiencing discomfort due to allergies. This medication is formulated to provide relief from itching, which can help improve the quality of life for affected pets.

Common effects of APOQUEL 3.6 MG may include reduced itching and inflammation in dogs. Some pets may experience mild side effects such as vomiting or diarrhea, although not all dogs will have these effects. It is important to monitor your pet for any unusual symptoms and consult your veterinarian if concerns arise.

APOQUEL 3.6 MG should be used as directed by a veterinarian. It is important to follow the prescribed dosage and administration instructions. This medication is not suitable for all dogs, particularly those with certain medical conditions or those taking specific medications. Always inform your veterinarian about any other treatments your pet is receiving.

APOQUEL 3.6 MG may interact with other medications, including those that suppress the immune system. It is crucial to discuss all current medications with your veterinarian to avoid potential interactions. Additionally, certain health conditions may affect the safety and effectiveness of oclacitinib, so a thorough health assessment is recommended before starting this treatment.